Plevritis SK - Search Results

1

A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.

Bailey SL, Sigal BM, Plevritis SK. Bailey SL, et al. Among authors: plevritis sk. J Natl Cancer Inst. 2010 Aug 18;102(16):1263-71. doi: 10.1093/jnci/djq271. Epub 2010 Jul 27. J Natl Cancer Inst. 2010. PMID: 20664027 Free PMC article.

2

Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer.

Yeh CY, Aguirre K, Laveroni O, Kim S, Wang A, Liang B, Zhang X, Han LM, Valbuena R, Bassik MC, Kim YM, Plevritis SK, Snyder MP, Howitt BE, Jerby L. Yeh CY, et al. Among authors: plevritis sk. Nat Immunol. 2024 Oct;25(10):1943-1958. doi: 10.1038/s41590-024-01943-5. Epub 2024 Aug 23. Nat Immunol. 2024. PMID: 39179931 Free PMC article.

3

A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening.

Plevritis SK. Plevritis SK. Math Biosci. 2001 Jun;171(2):155-78. doi: 10.1016/s0025-5564(01)00054-2. Math Biosci. 2001. PMID: 11395049

4

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.

Hartman AR, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK. Hartman AR, et al. Among authors: plevritis sk. Cancer. 2004 Feb 1;100(3):479-89. doi: 10.1002/cncr.11926. Cancer. 2004. PMID: 14745863 Free article. Clinical Trial.

5

The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.

Rosenberg J, Chia YL, Plevritis S. Rosenberg J, et al. Breast Cancer Res Treat. 2005 Jan;89(1):47-54. doi: 10.1007/s10549-004-1470-1. Breast Cancer Res Treat. 2005. PMID: 15666196

6

Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.

Kurian AW, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR. Kurian AW, et al. Among authors: plevritis sk. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1082-9. doi: 10.1158/1055-9965.EPI-04-0776. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894656

7

A natural history model of stage progression applied to breast cancer.

Plevritis SK, Salzman P, Sigal BM, Glynn PW. Plevritis SK, et al. Stat Med. 2007 Feb 10;26(3):581-95. doi: 10.1002/sim.2550. Stat Med. 2007. PMID: 16598706

8

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.

Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM. Plevritis SK, et al. JAMA. 2006 May 24;295(20):2374-84. doi: 10.1001/jama.295.20.2374. JAMA. 2006. PMID: 16720823

9

A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.

Plevritis SK, Sigal BM, Salzman P, Rosenberg J, Glynn P. Plevritis SK, et al. J Natl Cancer Inst Monogr. 2006;(36):86-95. doi: 10.1093/jncimonographs/lgj012. J Natl Cancer Inst Monogr. 2006. PMID: 17032898

10

Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis.

Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Cronin KA, et al. Among authors: plevritis sk. J Natl Cancer Inst Monogr. 2006;(36):112-21. doi: 10.1093/jncimonographs/lgj015. J Natl Cancer Inst Monogr. 2006. PMID: 17032901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters